September 25, 2017
Kelly Drye was mentioned in the Law360
article, “Drugmakers Beat Health Plan's Generic Price Inflation Suit” as representatives of Mylan Laboratories Inc. The Kelley Drye team consisting of partners William Escobar
and Cliff Katz
succeeded in obtaining dismissal of a class action suit against Mylan in the U.S. District Court for the Eastern District of Pennsylvania.
To read full article, please click here